Attention deficit hyperactivity disorder: Anxiety phenomena in children treated with psychostimulant medication for 6 months or more

Australian and New Zealand Journal of Psychiatry

Volumn 33, Issue 3, 1999, Pages 399-406

  Vance, Alasdair L A ^a   Luk, Ernest S L ^a   Costin, Jan ^a   Tonge, Bruce J ^b   Pantelis, Christos ^c  

^a Maroondah Child Adol Psychiat S   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

ADHD; Anxiety; Longer term; Psychostimulant medication

Indexed keywords

METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

AFFECTIVE NEUROSIS; ANOREXIA; ANXIETY NEUROSIS; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEADACHE; HUMAN; INSOMNIA; LONG TERM CARE; MALE; MOTOR DYSFUNCTION; PSYCHOLOGICAL ASPECT; PSYCHOSOCIAL WITHDRAWAL; SIDE EFFECT; STATISTICAL ANALYSIS; STOMACH DISEASE; VERTIGO;

ANXIETY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; CHI-SQUARE DISTRIBUTION; CHILD; DIAGNOSTIC ERRORS; DRUG RESISTANCE; FEMALE; HUMANS; MALE; TIME FACTORS; TREATMENT FAILURE;

EID: 0033031602     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1614.1999.00575.x     Document Type: Article

References (35)

1. National Health and Medical Research Council. Attention deficit hyperactivity disorder (ADHD). Canberra: Commonwealth of Australia, 1997.
2. Schachar R, Tannock R. Childhood hyperactivity and psychostimulants: a review of extended treatment studies. Journal of Child and Adolescent Psychopharmacology 1993; 3:81-97.
3. Schachar RJ, Tannock R, Cunningham C, Corkum PV. Behavioural, situational and temporal effects of treatment of ADHD with methylphenidate. Journal of the American Academy of Child and Adolescent Psychiatry 1997; 36:754-763.
4. Buitelaar Jan K, Van-der-Gaag RJ, Swaab-Barneveld H, Kuiper M. The prediction of clinical response to methylphenidate in children with attention deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 1995; 34:1025-1032.
5. Tannock R, Ickowicz A, Schachar R. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. Journal of the American Academy of Child and Adolescent Psychiatry 1995; 34:886-896.
6. Plizka SR, Maas JW, Javors MA, Rogeness GA. Urinary catecholamines in attention deficit hyperactivity disorder with and without comorbid anxiety. Journal of the American Academy of Child and Adolescent Psychiatry 1994; 33:1165-1994.
7. Urman R, Ickowicz A, Fulford P, Tannock R. An exaggerated cardiovascular response to methylphenidate in ADHD children with anxiety. Journal of Child and Adolescent Psychopharmacology 1995; 5:29-37.
8. Plizka SR. Comorbidity of attention deficit hyperactivity disorder and overanxious disorder. Journal of the American Academy of Child and Adolescent Psychiatry 1992; 31:197-203.
9. Jacobvitz D, Stroufe LA, Stewart M, Leffer N. Treatment of additional and hyperactivity problems in children with sympathomimetic drugs: a comprehensive review. Journal of the American Academy of Child and Adolescent Psychiatry 1990; 29:677-688.
10. Diagnostic and statistical manual of mental disorders. 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association, 1994
11. Wilens TE, Biederman J. The stimulants. Psychiatric Clinics of North America 1992; 15:191-222.
12. Ullman RK, Sleator EK. Responders, nonresponders and placebo responders among others during a treatment evaluation. Clinical Paediatrics 1986; 25:594-599.
13. Douglas VI, Barr RG, Desilets J, Sherman E. Do high doses of stimulants impair flexible thinking in attention deficit hyperactivity disorder? Journal of the American Academy of Child and Adolescent Psychiatry 1995; 34:877-885.
14. Ahmann PA, Waltonen SJ, Olson KA, Theye FW, Van Erem AJ, LaPlant RJ. Placebo-controlled evaluation of Ritalin side effects. Paediatrics 1993; 91:1101-1106.
15. Gillberg C, Melander H, von Knorring A-L et al. Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. Archives of General Psychiatry 1997; 54:857-864.
16. Kupietz SS, Winsberg BG, Richardson E, Maitinsky S, Mendell N. Effects of methylphenidate dosage in hyper-active reading-disabled children, I: behaviour and cognitive performance effects. Journal of the American Academy of Child and Adolescent Psychiatry 1988; 27:70-77.
17. Levy F. Side-effects of stimulant use. Journal of Paediatrics and Child Health 1993; 29:250-254.
18. Greenhill LL. Pharmacotherapy stimulants. Child and Adolescent Psychiatric Clinics of North America 1992; 1:411-447.
19. Diagnostic and statistical manual of mental disorders. 2nd ed. (DSM-II). Washington, DC: American Psychiatric Association, 1968.
20. Zahn TP, Abate F, Little BC, Wender PH. Minimal brain dysfunction, stimulant drugs and autonomie nervous system activity. Archives of General Psychiatry 1975; 32:381-387.
21. Swanson JM, Kinsbourne M, Roberts W, Zucker K. Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Paediatrics 1978; 61:21-29.
22. Taylor E, Schachar R, Thorley G, Wieselberg M. Conduct disorder and hyperactivity: I. Separation of hyperactivity and antisocial conduct in British child psychiatric patients. British Journal of Psychiatry 1986; 149:760-777.
23. Taylor E, Everitt B, Schachar R, Thorley G, Rutter M, Wieselberg M. Conduct disorder and hyperactivity: II. A cluster analytic approach to the identification of a behavioural syndrome. British Journal of Psychiatry 1986; 149:760-777.
24. Taylor E, Schachar R, Thorley G, Wieselberg HM, Everitt B, Rutter M. Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour. Psychological Medicine 1987; 17:121-143.
25. Pliszka SR. Effect of anxiety on cognition, behaviour and stimulant response in ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 1989; 28:882-887.
26. Achenbach TM, Edelbrock CS. Manual for the child behaviour checklist and behaviour profile. Burlington: University of Vermont, 1983.
27. Costello EJ, Edelbrock CS, Costello AJ. Validity of the NIMH diagnostic interview schedule for children: a comparison between psychiatric referrals and paediatric referrals. Journal of Abnormal Child Psychology 1985; 13:579-595.
28. Reynolds CR, Richmond BO. Revised children's manifest anxiety scale manual. Los Angeles: Western Psychological Services, 1985.
29. Wechsler D. Wechsler intelligence scale for children. 3rd ed. Texas: The Psychological Co-operation, 1991.
30. Jastak S, Wilkinson GS. Wide range achievement test-revised. Wilmington, DE: Jastak Assessment Systems, 1984.
31. Neale MD. Neale analysis of reading ability revised. Melbourne: Australian Council for Educational Research, 1988.
32. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. American Journal of Psychiatry 1991; 148:564-577.
33. Plizka SR. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. Journal of Clinical Psychiatry 1998; 59(Suppl. 7):50-58.
34. Biederman J. Attention deficit hyeractivity disorder. Annals of Clinical Psychiatry 1990; 3:9-22.
35. Wilens TE, Spencer T, Biederman J, Wozianek J. Combined pharmacotherapy: an emerging trend in paediatric psychopharmacology. Journal of the American Academy of Child and Adolescent Psychiatry 1995; 34:110-112.